Open company graph database — free web & API
Login

KaneKa Medicals Inc.

株式会社カネカメディックスKaneka Medix CorporationAlias
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
399
Related companies
0
§01

Basic information

BASIC
Head office
2-3-18 Nakanojo, Kita-ku, Osaka (34th floor, Nakanojo Festival Tower)
Chief executive
Not disclosed
Capital
450,000,000  (4 100 million)
Employees (non-consolidated)
399 people
Employees (consolidated)
Start date
1993-09-01
End date
§02

Websites

1 DOMAINS
§03

Business

3
Sale of medical productsHosting seminars for healthcare professionalsOperating a membership site for healthcare professionals
§04

Related companies

0 COMPANIES

—

§05

Network

NETWORK
Drag to move · click to open
§06

History

55 EVENTS

Entered the medical device business through blood purification and started selling adsorption-type plasma purifiersSources

Sales of adsorption-type plasma purifier began in 1986.Sources

Established KaneKa Medicals Inc.Sources

Established Zhonghua Medical Co., Ltd. in 1987.Sources

Inherited the iconic medical tube brand 'Shirascon®' from Dow Corning and began salesSources

In 1993, inherited the iconic medical catheter brand 'SILASCON®' from Dako Corporation and began sales.Sources

The company was established in September 1993 by Zhongyuan Chemical Industrial Co., Ltd. (now Zhonghua Co., Ltd.) with full funding.Sources

Started selling tear duct tubes and entered the ophthalmology fieldSources

In 1994, began sales of tear duct catheters and entered the ophthalmology field.Sources

Started selling PTCA balloon catheters and entered the cardiovascular fieldSources

In 1996, began sales of PTCA balloon catheters and entered the circulatory device field.Sources

Obtained FDA approval for the adsorption-type plasma purification system and moved the Tokyo office to TennōzuSources

1997: The adsorption-type plasma purification system received FDA approval, and the Tokyo business office was relocated to Tennozu.Sources

Started selling adsorption-type blood purifiersSources

Sales of adsorption-type blood purifier began in 1999.Sources

Birth of the TRANVAS brand and integration of intervention business salesSources

The TRANVAS brand was born in 2000, and the sales of Zhonghua interventional business were merged into Zhonghua Medical Co., Ltd.Sources

Founded BioMasterSources

Biomaster was founded in 2001.Sources

Started selling aneurysm embolization coils and entered neurosurgery, began selling PTCA balloon catheters, thrombus suction catheters, and penetration catheters, and opened a logistics center within the Osaka plantSources

In 2002, began sales of aneurysm embolization coils, PTA balloon catheters, thrombus aspiration catheters, puncture catheters, and established Zhonghua Medical Osaka Logistics Center within Zhonghua Osaka factory.Sources

Integrated sales of the blood purification businessSources

In 2003, merged sales of Zhonghua blood purification business into Zhonghua Medical Co., Ltd.Sources

Started selling blood flow meters, PTCA balloon catheters, entered peripheral field, and opened Cellport Clinic YokohamaSources

2005: Began sales of blood flow measurement devices and PTA balloon catheters, entered peripheral field, opened Yokohama CELLPORT clinic.Sources

Established KaneKa Pharma Vietnam (now KaneKa Medical Vietnam)Sources

2006: Established Zhonghua Pharmaceutical Vietnam Company (now Zhonghua Medical Vietnam Company).Sources

Established a customer service center in TennōzuSources

2007: Opened a customer service center in Tennōzu.Sources

Opened the Tokyo logistics centerSources

2008: Tokyo Logistics Center established.Sources

Moved the Sapporo and Nagoya officesSources

2009: Relocated Sapporo and Nagoya offices.Sources

Started overseas expansion of PTCA balloon catheters (areas: EMEA, ASEAN, Australia, New Zealand, India), established River Seiko through acquisition of River Seiko shares, and opened Sendai officeSources

2010: Began expanding overseas business of PTCA balloon catheters (regions: EMEA, ASEAN, Australia, New Zealand, India), acquired shares of 'River Seiko', and established the Sendai office.Sources

Launch of blood purification products (adsorption-type blood purifiers) overseas (Regions: EMEA, North America, Latin America).Sources

2013: Began expanding overseas business of blood purification products (adsorption-type blood purifiers) (regions: EMEA, North America, Latin America).Sources

Launch of PTA balloon catheter (for peripheral vessels) overseas (Region: China), launch of tear duct tube overseas (Region: North America), launch of embolization coils for cerebral aneurysm treatment overseas (Regions: EMEA, Vietnam, Latin America), opening of Hiroshima office.Sources

2014: Began expanding overseas business of PTA balloon catheters (for peripheral vessels) in China, began expanding overseas business of tear duct catheters in North America, began expanding overseas business of cerebral aneurysm embolization coils in EMEA, Vietnam, Latin America, and established the Hiroshima office.Sources

Adsorption-type blood purifier obtains FDA approval, launch of biliary dilation balloon catheter, entry into the gastrointestinal field, opening of Settsu office.Sources

2015: Adsorptive blood purifier received FDA approval, began sales of biliary dilation balloon catheters, entered gastrointestinal field, established Settsu branch.Sources

Relocation of Tokyo office and customer service center to Akasaka.Sources

2016: Relocated the Tokyo business office and customer service center to Akasaka.Sources

2017Sources

Launch of electrode catheter, entry into arrhythmia field, change of company name from Riverseiko to Kaneka Medical Tech.Sources

2019: Began sales of electrode catheters, entered arrhythmia field, company name changed from 'River Seiko' to 'Zhonghua Medical Technology'.Sources

Launch of metallic stent for bile ducts, launch of pleural and peritoneal fluid concentration filters and filtration filters, completion of Kaneka Medical Vietnam medical device new factory.Sources

2020: Began sales of biliary metal stents, thoracic/abdominal effusion concentrator filters, completed new medical device plant of Zhonghua Medical Vietnam Company.Sources

Kaneka Japan Medical Device Research & Development becomes a wholly-owned subsidiary.Sources

2022: Zhonghua made Japanese Medical Device Technical Research Company a wholly-owned subsidiary.Sources

Completion of Kaneka Tomo East factory, signing of exclusive Japanese sales agreement for Kaneka Israel's cerebral thrombus retrieval device.Sources

2023: The Zhonghua Tomo East factory was completed, and a Japan-exclusive sales contract for an Israeli company's cerebral thrombus retrieval device was signed.Sources

2024: Began sales of nipple incision knife, cutting-type PTCA balloon, intracardiac defibrillation electrode catheter, stroke treatment device; Zhonghua signed a transfer agreement of its medical device division with Japan's Seion Medical Co., Ltd. group.Sources

Launch of plastic stent for bile ducts.Sources

2025: Began selling plastic stents for bile ducts, began selling balloon catheters for bronchial dilation, and started expanding overseas business of intracranial aneurysm embolization springs (region: Europe).Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑